Marty J Duvall
Marty J Duvall was appointed as CEO in 2020.
Marty has extensive experience from executive leadership roles in drug development and commercialization within the global biotechnology and pharmaceutical industry, including a unique experience from the oncology and hematology sphere.
Prior to joining Oncopeptides Marty was Chief Executive Officer...
Roles at Oncopeptides AB